Kidney Transplantation in Highly Sensitized Patients
Nephrology
4
Pipeline Programs
1
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Hansa BiopharmaSweden - Lund
5 programs2
2
ImlifidasePhase 31 trial
ImlifidasePhase 31 trial
ImlifidasePhase 21 trial
ImlifidasePhase 21 trial
Imlifidase administered in the ConfIdeS studyN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Hansa BiopharmaImlifidase
Hansa BiopharmaImlifidase
Hansa BiopharmaImlifidase
Hansa BiopharmaImlifidase
Hansa BiopharmaImlifidase administered in the ConfIdeS study
Clinical Trials (5)
Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
Start: Apr 2022Est. completion: Apr 2026
Phase 3Active Not Recruiting
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
Start: Oct 2021Est. completion: Jun 2025
Phase 3Completed
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Start: Jun 2023Est. completion: Aug 2031
Phase 2Recruiting
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
Start: Dec 2022Est. completion: May 2024
Phase 2Terminated
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
Start: Apr 2023Est. completion: Dec 2029
N/AActive Not Recruiting
Related Jobs in Nephrology
Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
Sweden - Gothenburg
1w ago
Associate Director – Nephrology Market Access Strategy
Biogen
Cambridge, MA
1w ago
$164K - $226K/yr
Director, Strategy & Operations-Nephrology Franchise
Biogen
Cambridge, MA
1w ago
$195K - $269K/yr
Medical Science Liaison, CardioRenal - Portland, OR
AstraZeneca
Portland - OR, US
1w ago
Vice President, Head of Renal Sales
Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr
Specialty Account Manager, Nephrology- South Houston, Texas
Amgen
Texas - Houston, US
1w ago
$155K - $184K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space